neuroscience

Transcript, Meeting 19, Session 3

SESSION 3: MEMBER DISCUSSION [CONSENT CAPACITY FRAMING AND POSSIBLE RECOMMENDATIONS]

Date

Wed, 11/05/2014

Transcript, Meeting 19, Opening Remarks and Session 1

DR. GUTMANN:  Welcome everybody.  I'm Amy Gutmann.  I'm President of the University of Pennsylvania.  And I'm Director and Chair of the Presidential Commission for the Study of Bioethical Issues.  And on behalf of myself and our Vice Chair, Jim Wagner, and all of our Commission members, I'd like to welcome you to this, our nineteenth meeting. I will begin by noting the presence of our designated federal official, Bioethics Commission Executive Director Lisa M. Lee.  Lisa, please stand up. Thank you.

Date

Wed, 11/05/2014

Transcript, Meeting 19, Session 4 and Closing Remarks

DR. GUTMANN:  So we are turning now to our third specific topic, Neuroscience and Law.  And we can take this work in many directions.  But certainly some fundamental questions that involve whether and how to use neuroscience technologies in the courtroom.  For example, what can neuroscience in its current capacity tell us about whether any individual is legally blameworthy for his or her actions?  What is the potential for neuroscience to answer this question?

Date

Wed, 11/05/2014

Agenda for Meeting 18: Aug. 20, 2014 in Washington, D.C.

Hamilton Crowne Plaza Hotel
1001 14th Street, NW
Washington, DC 20005

Wednesday, August 20

9:00 – 9:15 a.m.  Welcome and Opening Remarks

Amy Gutmann, Ph.D.
Commission Chair

James Wagner, Ph.D.
Commission Vice Chair

9:15 – 10:30 a.m. Session 1: Ethical Considerations in Cognitive Enhancement

Pages

Subscribe to RSS - neuroscience

This is a work of the U.S. Government and is not subject to copyright protection in the United States. Foreign copyrights may apply.